Evolent Health, Inc. (EVH)
USD 9.06
(4.68%)
USD 9.06
(4.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.68 Billion USD | 47.49% |
| 2022 | 1.81 Billion USD | 28.03% |
| 2021 | 1.41 Billion USD | 3.6% |
| 2020 | 1.37 Billion USD | -8.53% |
| 2019 | 1.49 Billion USD | -13.02% |
| 2018 | 1.72 Billion USD | 31.2% |
| 2017 | 1.31 Billion USD | 9.41% |
| 2016 | 1.19 Billion USD | 18.15% |
| 2015 | 1.01 Billion USD | 2553.07% |
| 2014 | 38.27 Million USD | -62.46% |
| 2013 | 101.97 Million USD | 525.46% |
| 2012 | 16.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.64 Billion USD | -1.37% |
| 2024 Q2 | 2.47 Billion USD | -6.38% |
| 2023 Q4 | 2.68 Billion USD | 0.4% |
| 2023 FY | 2.68 Billion USD | 47.49% |
| 2023 Q2 | 2.64 Billion USD | 2.22% |
| 2023 Q3 | 2.66 Billion USD | 0.86% |
| 2023 Q1 | 2.58 Billion USD | 42.49% |
| 2022 Q4 | 1.81 Billion USD | 3.3% |
| 2022 FY | 1.81 Billion USD | 28.03% |
| 2022 Q3 | 1.75 Billion USD | 34.92% |
| 2022 Q2 | 1.3 Billion USD | -2.63% |
| 2022 Q1 | 1.33 Billion USD | -5.66% |
| 2021 Q3 | 1.25 Billion USD | -3.08% |
| 2021 Q1 | 1.3 Billion USD | -4.71% |
| 2021 Q2 | 1.29 Billion USD | -0.94% |
| 2021 FY | 1.41 Billion USD | 3.6% |
| 2021 Q4 | 1.41 Billion USD | 13.24% |
| 2020 Q1 | 1.45 Billion USD | -3.09% |
| 2020 Q3 | 1.39 Billion USD | 9.58% |
| 2020 Q4 | 1.37 Billion USD | -1.55% |
| 2020 FY | 1.37 Billion USD | -8.53% |
| 2020 Q2 | 1.27 Billion USD | -12.51% |
| 2019 Q4 | 1.49 Billion USD | -12.6% |
| 2019 FY | 1.49 Billion USD | -13.02% |
| 2019 Q1 | 1.62 Billion USD | -5.39% |
| 2019 Q3 | 1.71 Billion USD | 3.73% |
| 2019 Q2 | 1.65 Billion USD | 1.4% |
| 2018 FY | 1.72 Billion USD | 31.2% |
| 2018 Q4 | 1.72 Billion USD | 30.21% |
| 2018 Q3 | 1.32 Billion USD | 0.08% |
| 2018 Q2 | 1.32 Billion USD | 1.17% |
| 2018 Q1 | 1.3 Billion USD | -0.49% |
| 2017 Q2 | 1.13 Billion USD | -1.39% |
| 2017 Q3 | 1.29 Billion USD | 14.11% |
| 2017 FY | 1.31 Billion USD | 9.41% |
| 2017 Q1 | 1.15 Billion USD | -3.78% |
| 2017 Q4 | 1.31 Billion USD | 1.05% |
| 2016 FY | 1.19 Billion USD | 18.15% |
| 2016 Q1 | 860.06 Million USD | -15.31% |
| 2016 Q2 | 852.8 Million USD | -0.84% |
| 2016 Q4 | 1.19 Billion USD | 40.95% |
| 2016 Q3 | 851.28 Million USD | -0.18% |
| 2015 Q1 | 76.43 Million USD | 99.69% |
| 2015 Q2 | 1.03 Billion USD | 1260.44% |
| 2015 Q4 | 1.01 Billion USD | -3.85% |
| 2015 Q3 | 1.05 Billion USD | 1.57% |
| 2015 FY | 1.01 Billion USD | 2553.07% |
| 2014 FY | 38.27 Million USD | -62.46% |
| 2014 Q1 | - USD | -100.0% |
| 2014 Q4 | 38.27 Million USD | -60.97% |
| 2014 Q3 | 98.06 Million USD | 0.0% |
| 2013 FY | 101.97 Million USD | 525.46% |
| 2013 Q4 | 101.97 Million USD | 0.0% |
| 2012 FY | 16.3 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Well Corporation | 589.7 Million USD | -354.517% |
| Doximity, Inc. | 1.07 Billion USD | -148.321% |
| MultiPlan Corporation | 7.1 Billion USD | 62.279% |
| Phreesia, Inc. | 371.08 Million USD | -622.29% |
| Teladoc Health, Inc. | 4.39 Billion USD | 38.978% |
| Veeva Systems Inc. | 5.91 Billion USD | 54.655% |